CGRP-receptor antagonists--a fresh approach to migraine therapy?
Durham
Paul L
PL
Department of Biology, Southwest Missouri State University, Springfield, USA.
D000208:Acute Disease; D015740:Calcitonin Gene-Related Peptide / Q000502:physiology*; D000077221:Calcitonin Gene-Related Peptide Receptor Antagonists; D005260:Female; D006801:Humans; D008297:Male; D008881:Migraine Disorders / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D010879:Piperazines; D010880:Piperidines / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*; D018015:Receptors, Calcitonin Gene-Related Peptide / Q000502:physiology
D000077221:Calcitonin Gene-Related Peptide Receptor Antagonists; D010879:Piperazines; D010880:Piperidines; D011799:Quinazolines; D018015:Receptors, Calcitonin Gene-Related Peptide; D015740:Calcitonin Gene-Related Peptide; C406305:olcegepant